Laberon

Beclometasone Dipropionate, the active ingredient in Laberon, is an inhaled corticosteroid/long‑acting β2‑agonist combination presented as an inhalation aerosol (metered‑dose inhaler) for inhalation use. It treats asthma and chronic obstructive pulmonary disease (COPD) as maintenance therapy in adults and children.\n\nGNH India supplies Laberon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laberon, a combination inhaled corticosteroid and long‑acting β2‑agonist, is used in the management of obstructive airway diseases.\n\nAsthma: provides maintenance control of symptoms and reduces the frequency of exacerbations.\nCOPD: improves lung function and lowers the risk of flare‑ups.

Laberon may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Throat irritation or soreness\n- Hoarseness or voice change\n- Cough\n- Oral candidiasis (thrush)\n- Headache\n- Tremor\n\nSerious or Rare Side Effects:\n- Paradoxical bronchospasm\n- Severe allergic reaction (anaphylaxis)\n- Adrenal suppression\n- Pneumonia\n- Cardiac arrhythmia\n- Hyperglycemia

Before prescribing Laberon, clinicians should consider several safety measures.\n\nAssess disease control: verify that asthma or COPD is not well‑controlled on other therapy.\nMonitor for oral thrush: advise patients to rinse mouth after each inhalation.\nUse a spacer device: reduces oropharyngeal deposition.\nAvoid abrupt discontinuation: taper if long‑term use is planned.\nReview concomitant β‑blocker use: may diminish bronchodilator effect.\nStore at ambient temperature: keep in original container, protect from moisture and heat.

Laberon can interact with other medicines, requiring attention to dosage and monitoring.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inhibitors (e.g., ketoconazole) may increase systemic corticosteroid exposure.\n- Non‑selective β‑blockers can blunt bronchodilator response.\n- Loop diuretics may heighten risk of hypokalemia when combined with β2‑agonists.\n\nModerate Interactions (Monitor Closely):\n- Antidiabetic agents: glucocorticoid component may raise blood glucose.\n- Anticholinergic drugs: additive anticholinergic effects may occur.\n- Theophylline: inhaled corticosteroids can increase theophylline levels.